O	0	1	A	A	DT	B-NP
O	2	11	potential	potential	JJ	I-NP
O	12	16	role	role	NN	I-NP
O	17	20	for	for	IN	B-PP
O	21	24	the	the	DT	B-NP
O	25	28	Src	Src	NN	I-NP
O	28	29	-	-	HYPH	B-NP
O	29	33	like	like	JJ	I-NP
O	34	41	adapter	adapter	NN	I-NP
O	42	49	protein	protein	NN	I-NP
O	50	54	SLAP	SLAP	NN	I-NP
O	54	55	-	-	HYPH	O
O	55	56	2	2	CD	B-NP
O	57	59	in	in	IN	B-PP
O	60	69	signaling	signaling	NN	B-NP
O	70	72	by	by	IN	B-PP
O	73	76	the	the	DT	B-NP
O	77	83	colony	colony	NN	I-NP
O	84	95	stimulating	stimulating	NN	I-NP
O	96	102	factor	factor	NN	I-NP
O	102	103	-	-	HYPH	B-NP
O	103	104	1	1	CD	I-NP
O	105	113	receptor	receptor	NN	I-NP
O	113	114	.	.	.	O

O	115	118	The	The	DT	B-NP
O	119	130	development	development	NN	I-NP
O	131	133	of	of	IN	B-PP
B-Cell	134	145	macrophages	macrophage	NNS	B-NP
O	146	150	from	from	IN	B-PP
B-Cell	151	158	myeloid	myeloid	JJ	B-NP
I-Cell	159	169	progenitor	progenitor	NN	I-NP
I-Cell	170	175	cells	cell	NNS	I-NP
O	176	178	is	be	VBZ	B-VP
O	179	188	primarily	primarily	RB	I-VP
O	189	199	controlled	control	VBN	I-VP
O	200	202	by	by	IN	B-PP
O	203	206	the	the	DT	B-NP
O	207	213	growth	growth	NN	I-NP
O	214	220	factor	factor	NN	I-NP
O	221	227	colony	colony	NN	I-NP
O	228	239	stimulating	stimulating	NN	I-NP
O	240	246	factor	factor	NN	I-NP
O	246	247	-	-	HYPH	B-NP
O	247	248	1	1	CD	I-NP
O	249	250	(	(	(	O
O	250	253	CSF	CSF	NN	B-NP
O	253	254	-	-	HYPH	B-NP
O	254	255	1	1	CD	I-NP
O	255	256	)	)	)	O
O	257	260	and	and	CC	O
O	261	264	its	its	PRP$	B-NP
O	265	272	cognate	cognate	JJ	I-NP
O	273	281	receptor	receptor	NN	I-NP
O	281	282	,	,	,	O
O	283	284	a	a	DT	B-NP
B-Cellular_component	285	298	transmembrane	transmembrane	JJ	I-NP
O	299	307	tyrosine	tyrosine	NN	I-NP
O	308	314	kinase	kinase	NN	I-NP
O	315	322	encoded	encode	VBN	B-VP
O	323	325	by	by	IN	B-PP
O	326	329	the	the	DT	B-NP
O	330	331	c	c	NN	I-NP
O	331	332	-	-	HYPH	B-NP
O	332	335	Fms	Fm	NNPS	I-NP
O	336	341	proto	proto	AFX	B-NP
O	341	342	-	-	HYPH	I-NP
O	342	350	oncogene	oncogene	NN	B-NP
O	350	351	.	.	.	O

O	352	355	The	The	DT	B-NP
O	356	359	CSF	CSF	NN	I-NP
O	359	360	-	-	HYPH	B-NP
O	360	361	1	1	CD	I-NP
O	362	370	receptor	receptor	NN	I-NP
O	371	377	exerts	exert	VBZ	B-VP
O	378	381	its	its	PRP$	B-NP
O	382	392	biological	biological	JJ	I-NP
O	393	400	effects	effect	NNS	I-NP
O	401	403	on	on	IN	B-PP
B-Cell	404	409	cells	cell	NNS	B-NP
O	410	413	via	via	IN	B-PP
O	414	415	a	a	DT	B-NP
O	416	421	range	range	NN	I-NP
O	422	424	of	of	IN	B-PP
O	425	434	signaling	signaling	NN	B-NP
O	435	443	proteins	protein	NNS	I-NP
O	444	453	including	include	VBG	B-PP
O	454	458	Erk1	Erk1	NN	B-NP
O	458	459	/	/	SYM	O
O	459	460	2	2	CD	B-NP
O	461	464	and	and	CC	O
O	465	468	Akt	Akt	NNP	B-NP
O	468	469	.	.	.	O

O	470	474	Here	Here	RB	B-ADVP
O	475	477	we	we	PRP	B-NP
O	478	482	have	have	VBP	B-VP
O	483	495	investigated	investigate	VBN	I-VP
O	496	499	the	the	DT	B-NP
O	500	509	potential	potential	JJ	I-NP
O	510	521	involvement	involvement	NN	I-NP
O	522	524	of	of	IN	B-PP
O	525	528	the	the	DT	B-NP
O	529	532	Src	Src	NN	I-NP
O	532	533	-	-	HYPH	B-NP
O	533	537	like	like	JJ	I-NP
O	538	545	adapter	adapter	NN	I-NP
O	546	553	protein	protein	NN	I-NP
O	554	555	(	(	(	O
O	555	559	SLAP	SLAP	NN	B-NP
O	559	560	-	-	HYPH	O
O	560	561	2	2	CD	B-NP
O	561	562	)	)	)	O
O	563	565	in	in	IN	B-PP
O	566	575	signaling	signaling	NN	B-NP
O	576	578	by	by	IN	B-PP
O	579	582	the	the	DT	B-NP
O	583	586	CSF	CSF	NN	I-NP
O	586	587	-	-	HYPH	B-NP
O	587	588	1	1	CD	I-NP
O	589	597	receptor	receptor	NN	I-NP
O	598	600	in	in	IN	B-PP
O	601	606	mouse	mouse	NN	B-NP
B-Multi-tissue_structure	607	611	bone	bone	NN	I-NP
I-Multi-tissue_structure	612	618	marrow	marrow	NN	I-NP
O	618	619	-	-	HYPH	O
O	619	626	derived	derive	VBN	B-VP
B-Cell	627	638	macrophages	macrophage	NNS	B-NP
O	638	639	.	.	.	O

O	640	642	RT	RT	NN	B-NP
O	642	643	-	-	HYPH	I-NP
O	643	646	PCR	PCR	NN	I-NP
O	647	655	analysis	analysis	NN	I-NP
O	656	664	revealed	reveal	VBD	B-VP
O	665	677	constitutive	constitutive	JJ	B-NP
O	678	688	expression	expression	NN	I-NP
O	689	691	of	of	IN	B-PP
O	692	695	the	the	DT	B-NP
O	696	700	SLAP	SLAP	NN	I-NP
O	700	701	-	-	HYPH	B-NP
O	701	702	2	2	CD	I-NP
O	703	707	gene	gene	NN	I-NP
O	708	710	in	in	IN	B-PP
B-Cell	711	715	bone	bone	NN	B-NP
I-Cell	716	722	marrow	marrow	NN	I-NP
I-Cell	723	734	macrophages	macrophage	NNS	I-NP
O	734	735	.	.	.	O

O	736	748	Surprisingly	Surprisingly	RB	B-ADVP
O	748	749	,	,	,	O
O	750	752	co	co	AFX	B-NP
O	752	753	-	-	HYPH	I-NP
O	753	772	immunoprecipitation	immunoprecipitation	NN	I-NP
O	773	776	and	and	CC	I-NP
O	777	780	GST	GST	NN	I-NP
O	781	788	binding	binding	NN	I-NP
O	789	800	experiments	experiment	NNS	I-NP
O	801	813	demonstrated	demonstrate	VBD	B-VP
O	814	818	that	that	IN	B-SBAR
O	819	822	the	the	DT	B-NP
O	823	826	CSF	CSF	NN	I-NP
O	826	827	-	-	HYPH	B-NP
O	827	828	1	1	CD	I-NP
O	829	837	receptor	receptor	NN	I-NP
O	838	843	could	could	MD	B-VP
O	844	848	bind	bind	VB	I-VP
O	849	851	to	to	TO	B-PP
O	852	856	SLAP	SLAP	NN	B-NP
O	856	857	-	-	HYPH	O
O	857	858	2	2	CD	B-NP
O	859	861	in	in	IN	B-PP
O	862	863	a	a	DT	B-NP
O	864	870	ligand	ligand	NN	I-NP
O	870	871	-	-	HYPH	B-NP
O	871	882	independent	independent	JJ	I-NP
O	883	889	manner	manner	NN	I-NP
O	889	890	.	.	.	O

O	891	902	Furthermore	Furthermore	RB	B-ADVP
O	902	903	,	,	,	O
O	904	907	the	the	DT	B-NP
O	908	915	binding	binding	NN	I-NP
O	916	918	of	of	IN	B-PP
O	919	923	SLAP	SLAP	NN	B-NP
O	923	924	-	-	HYPH	O
O	924	925	2	2	CD	B-NP
O	926	928	to	to	TO	B-PP
O	929	932	the	the	DT	B-NP
O	933	936	CSF	CSF	NN	I-NP
O	936	937	-	-	HYPH	B-NP
O	937	938	1	1	CD	I-NP
O	939	947	receptor	receptor	NN	I-NP
O	948	956	involved	involve	VBD	B-VP
O	957	965	multiple	multiple	JJ	B-NP
O	966	973	domains	domain	NNS	I-NP
O	974	976	of	of	IN	B-PP
O	977	981	SLAP	SLAP	NN	B-NP
O	981	982	-	-	HYPH	B-NP
O	982	983	2	2	CD	I-NP
O	983	984	.	.	.	O

O	985	989	SLAP	SLAP	NN	B-NP
O	989	990	-	-	HYPH	I-NP
O	990	991	2	2	CD	I-NP
O	992	996	also	also	RB	B-ADVP
O	997	1002	bound	bind	VBD	B-VP
O	1003	1004	c	c	NN	B-NP
O	1004	1005	-	-	HYPH	O
O	1005	1008	Cbl	Cbl	NN	B-NP
O	1008	1009	,	,	,	O
O	1010	1014	with	with	IN	B-PP
O	1015	1018	the	the	DT	B-NP
O	1019	1030	interaction	interaction	NN	I-NP
O	1031	1036	being	be	VBG	B-VP
O	1037	1045	mediated	mediate	VBN	I-VP
O	1045	1046	,	,	,	O
O	1047	1049	at	at	IN	B-ADVP
O	1050	1055	least	least	JJS	I-ADVP
O	1056	1058	in	in	IN	B-PP
O	1059	1063	part	part	NN	B-NP
O	1063	1064	,	,	,	O
O	1065	1067	by	by	IN	B-PP
O	1068	1071	the	the	DT	B-NP
O	1072	1078	unique	unique	JJ	I-NP
O	1079	1080	C	C	NN	I-NP
O	1080	1081	-	-	HYPH	B-NP
O	1081	1089	terminal	terminal	JJ	I-NP
O	1090	1096	domain	domain	NN	I-NP
O	1097	1099	of	of	IN	B-PP
O	1100	1104	SLAP	SLAP	NN	B-NP
O	1104	1105	-	-	HYPH	B-NP
O	1105	1106	2	2	CD	I-NP
O	1106	1107	.	.	.	O

O	1108	1122	Overexpression	Overexpression	NN	B-NP
O	1123	1125	of	of	IN	B-PP
O	1126	1130	SLAP	SLAP	NN	B-NP
O	1130	1131	-	-	HYPH	B-NP
O	1131	1132	2	2	CD	I-NP
O	1133	1135	in	in	IN	B-PP
B-Cell	1136	1140	bone	bone	NN	B-NP
I-Cell	1141	1147	marrow	marrow	NN	I-NP
I-Cell	1148	1159	macrophages	macrophage	NNS	I-NP
O	1160	1169	partially	partially	RB	B-ADVP
O	1170	1180	suppressed	suppress	VBD	B-VP
O	1181	1184	the	the	DT	B-NP
O	1185	1188	CSF	CSF	NN	I-NP
O	1188	1189	-	-	HYPH	B-NP
O	1189	1190	1	1	CD	I-NP
O	1190	1191	-	-	HYPH	B-NP
O	1191	1198	induced	induce	VBN	I-NP
O	1199	1207	tyrosine	tyrosine	NN	I-NP
O	1208	1223	phosphorylation	phosphorylation	NN	I-NP
O	1224	1227	and	and	CC	O
O	1227	1228	/	/	SYM	B-NP
O	1228	1230	or	or	CC	O
O	1231	1241	expression	expression	NN	B-NP
O	1242	1247	level	level	NN	I-NP
O	1248	1250	of	of	IN	B-PP
O	1251	1252	a	a	DT	B-NP
O	1253	1266	approximately	approximately	RB	I-NP
O	1267	1269	80	80	CD	I-NP
O	1270	1273	kDa	kDa	NN	I-NP
O	1274	1281	protein	protein	NN	I-NP
O	1282	1289	without	without	IN	B-PP
O	1290	1299	affecting	affect	VBG	B-VP
O	1300	1303	CSF	CSF	NN	B-NP
O	1303	1304	-	-	HYPH	B-NP
O	1304	1305	1	1	CD	I-NP
O	1305	1306	-	-	HYPH	B-NP
O	1306	1313	induced	induce	VBN	I-NP
O	1314	1320	global	global	JJ	I-NP
O	1321	1329	tyrosine	tyrosine	NN	I-NP
O	1330	1345	phosphorylation	phosphorylation	NN	I-NP
O	1345	1346	,	,	,	O
O	1347	1349	or	or	CC	O
O	1350	1360	activation	activation	NN	B-NP
O	1361	1363	of	of	IN	B-PP
O	1364	1367	Akt	Akt	NN	B-NP
O	1368	1370	or	or	CC	I-NP
O	1371	1375	Erk1	Erk1	NN	I-NP
O	1375	1376	/	/	SYM	B-NP
O	1376	1377	2	2	CD	B-NP
O	1377	1378	.	.	.	O

O	1379	1392	Significantly	Significantly	RB	B-ADVP
O	1392	1393	,	,	,	O
O	1394	1397	CSF	CSF	NN	B-NP
O	1397	1398	-	-	HYPH	B-NP
O	1398	1399	1	1	CD	I-NP
O	1400	1411	stimulation	stimulation	NN	I-NP
O	1412	1419	induced	induce	VBD	B-VP
O	1420	1426	serine	serine	NN	B-NP
O	1427	1442	phosphorylation	phosphorylation	NN	I-NP
O	1443	1445	of	of	IN	B-PP
O	1446	1450	SLAP	SLAP	NN	B-NP
O	1450	1451	-	-	HYPH	B-NP
O	1451	1452	2	2	CD	I-NP
O	1452	1453	.	.	.	O

O	1454	1467	Pharmacologic	Pharmacologic	JJ	B-NP
O	1468	1478	inhibition	inhibition	NN	I-NP
O	1479	1481	of	of	IN	B-PP
O	1482	1490	specific	specific	JJ	B-NP
O	1491	1498	protein	protein	NN	I-NP
O	1499	1506	kinases	kinase	NNS	I-NP
O	1507	1515	revealed	reveal	VBD	B-VP
O	1516	1520	that	that	IN	B-SBAR
O	1521	1524	CSF	CSF	NN	B-NP
O	1524	1525	-	-	HYPH	B-NP
O	1525	1526	1	1	CD	I-NP
O	1526	1527	-	-	HYPH	B-NP
O	1527	1534	induced	induce	VBN	I-NP
O	1535	1550	phosphorylation	phosphorylation	NN	I-NP
O	1551	1553	of	of	IN	B-PP
O	1554	1558	SLAP	SLAP	NN	B-NP
O	1558	1559	-	-	HYPH	B-NP
O	1559	1560	2	2	CD	I-NP
O	1561	1564	was	be	VBD	B-VP
O	1565	1574	dependent	dependent	JJ	B-ADJP
O	1575	1577	on	on	IN	B-PP
O	1578	1581	JNK	JNK	NN	B-NP
O	1582	1590	activity	activity	NN	I-NP
O	1590	1591	.	.	.	O

O	1592	1597	Taken	Take	VBN	B-VP
O	1598	1606	together	together	RB	B-ADVP
O	1606	1607	,	,	,	O
O	1608	1611	our	our	PRP$	B-NP
O	1612	1619	results	result	NNS	I-NP
O	1620	1627	suggest	suggest	VBP	B-VP
O	1628	1632	that	that	IN	B-SBAR
O	1633	1637	SLAP	SLAP	NN	B-NP
O	1637	1638	-	-	HYPH	O
O	1638	1639	2	2	CD	B-NP
O	1640	1645	could	could	MD	B-VP
O	1646	1657	potentially	potentially	RB	I-VP
O	1658	1660	be	be	VB	I-VP
O	1661	1669	involved	involve	VBN	I-VP
O	1670	1672	in	in	IN	B-PP
O	1673	1682	signaling	signaling	NN	B-NP
O	1683	1685	by	by	IN	B-PP
O	1686	1689	the	the	DT	B-NP
O	1690	1693	CSF	CSF	NN	I-NP
O	1693	1694	-	-	HYPH	B-NP
O	1694	1695	1	1	CD	I-NP
O	1696	1704	receptor	receptor	NN	I-NP
O	1704	1705	.	.	.	O

